Search Results

There are 9265 results for: content related to: Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion

  1. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma

    Journal of Surgical Oncology

    Volume 111, Issue 5, April 1, 2015, Pages: 570–579, Chiara Colombo, Dario Baratti, Shigeki Kusamura, Marcello Deraco and Alessandro Gronchi

    Version of Record online : 28 OCT 2014, DOI: 10.1002/jso.23808

  2. Isolated limb infusion: A review

    Journal of Surgical Oncology

    Volume 100, Issue 2, 1 August 2009, Pages: 169–177, Hidde M. Kroon and John F. Thompson

    Version of Record online : 13 APR 2009, DOI: 10.1002/jso.21280

  3. Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

    British Journal of Surgery

    Volume 98, Issue 11, November 2011, Pages: 1573–1580, J. P. Deroose, D. J. Grünhagen, A. N. van Geel, J. H. W. de Wilt, A. M. M. Eggermont and C. Verhoef

    Version of Record online : 8 JUL 2011, DOI: 10.1002/bjs.7621

  4. Thirty-five years of isolated limb perfusion for melanoma: Indications and results

    British Journal of Surgery

    Volume 83, Issue 10, October 1996, Pages: 1319–1328, B. C. Vrouenraets, O. E. Nieweg and Dr B. B. R. Kroon

    Version of Record online : 7 DEC 2005, DOI: 10.1002/bjs.1800831004

  5. Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients

    Journal of Surgical Oncology

    Volume 105, Issue 6, 1 May 2012, Pages: 563–569, Jan P. Deroose, Albertus N. van Geel, Jacobus W.A. Burger, Alexander M.M. Eggermont and Cornelis Verhoef

    Version of Record online : 21 OCT 2011, DOI: 10.1002/jso.22121

  6. You have free access to this content
    The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model

    International Journal of Cancer

    Volume 132, Issue 11, 1 June 2013, Pages: 2694–2704, Timo L.M. ten Hagen, Ann L.B. Seynhaeve, Gisela aan de Wiel-Ambagtsheer, Ernst A. de Bruijn, Sandra T. van Tiel, Curzio Ruegg, Michael Meyring, Matthias Grell, Simon L. Goodman and Alexander M.M. Eggermont

    Version of Record online : 5 DEC 2012, DOI: 10.1002/ijc.27940

  7. Isolated limb perfusion for malignant melanoma

    Seminars in Surgical Oncology

    Volume 12, Issue 6, November/December 1996, Pages: 416–428, H. Richard Alexander Jr., Douglas L. Fraker and David L. Bartlett

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2388(199611/12)12:6<416::AID-SSU7>3.0.CO;2-D

  8. Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-α and melphalan

    Journal of Surgical Oncology

    Volume 103, Issue 5, 1 April 2011, Pages: 371–379, Florian Grabellus, Corinna Kraft, Sien-Yi Sheu-Grabellus, Sebastian Bauer, Lars E. Podleska, Thomas C. Lauenstein, Christoph Pöttgen, Margarethe J. Konik, Kurt W. Schmid and Georg Taeger

    Version of Record online : 11 MAR 2011, DOI: 10.1002/jso.21724

  9. Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma

    Cancer

    Jens Jakob and Peter Hohenberger

    Version of Record online : 19 MAY 2016, DOI: 10.1002/cncr.29991

  10. Radionuclide leakage monitoring during hyperthermic isolated limb perfusion for treatment of local melanoma metastasis in an extremity

    Clinical Physiology and Functional Imaging

    Volume 35, Issue 4, July 2015, Pages: 301–305, Ida F. Paulsen, Annette Hougaard Chakera, Grethe Schmidt, Jennifer Drejøe, Helle Klyver, Peter S. Oturai, Birger Hesse, Krystztof Drzewiecki and Jann Mortensen

    Version of Record online : 5 JUN 2014, DOI: 10.1111/cpf.12164

  11. You have free access to this content
    Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics

    Cancer

    Volume 80, Issue 11, 1 December 1997, Pages: 2084–2090, David L. Bartlett, Grace Ma, H. Richard Alexander, Steven K. Libutti and Douglas L. Fraker

    Version of Record online : 20 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19971201)80:11<2084::AID-CNCR7>3.0.CO;2-X

  12. Isolated limb perfusion with the tumor-targeting human monoclonal antibody–cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma

    Journal of Surgical Oncology

    Volume 107, Issue 2, 1 February 2013, Pages: 173–179, Francesco Papadia, Valeria Basso, Roberto Patuzzo, Andrea Maurichi, Annabella Di Florio, Luciano Zardi, Elisa Ventura, Reinerio González-Iglesias, Valeria Lovato, Leonardo Giovannoni, Annaelisa Tasciotti, Dario Neri, Mario Santinami, Hans D. Menssen and Franco De Cian

    Version of Record online : 4 JUN 2012, DOI: 10.1002/jso.23168

  13. Toxicity and morbidity of isolated limb perfusion

    Seminars in Surgical Oncology

    Volume 14, Issue 3, April/May 1998, Pages: 224–231, Bart C. Vrouenraets, Joost M. Klaase, Omgo E. Nieweg and Bin B. R. Kroon

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2388(199804/05)14:3<224::AID-SSU6>3.0.CO;2-A

  14. You have free access to this content
    Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma

    International Journal of Cancer

    Volume 136, Issue 4, 15 February, 2015, Pages: 965–976, Tim D. Pencavel, Michelle J. Wilkinson, David C. Mansfield, Aadil A. Khan, Rohit Seth, Eleni M. Karapanagiotou, Victoria Roulstone, Richard J. Aguilar, Nanhai G. Chen, Aladar A. Szalay, Andrew J. Hayes and Kevin J. Harrington

    Version of Record online : 22 JUL 2014, DOI: 10.1002/ijc.29059

  15. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients

    Journal of Surgical Oncology

    Volume 91, Issue 2, 1 August 2005, Pages: 107–111, R.B. Takkenberg, B.C. Vrouenraets, A.N. van Geel, O.E. Nieweg, E.M. Noorda, A.M.M. Eggermont and B.B.R. Kroon

    Version of Record online : 18 JUL 2005, DOI: 10.1002/jso.20297

  16. Results of isolated lower limb perfusion for loco-regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases

    Journal of Surgical Oncology

    Volume 104, Issue 7, 1 December 2011, Pages: 718–723, Marcello Pace, Riccardo Gattai, Erminia M. Mascitelli and Luigi Millanta

    Version of Record online : 30 JUN 2011, DOI: 10.1002/jso.21949

  17. Isolated limb perfusion in primary and recurrent melanoma: Indications and results

    Seminars in Surgical Oncology

    Volume 14, Issue 3, April/May 1998, Pages: 202–209, Danielle Liénard, Alexander M. Eggermont, Bin B. R. Kroon, Heimen Schraffordt Koops and Ferdinand J. Lejeune

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2388(199804/05)14:3<202::AID-SSU3>3.0.CO;2-C

  18. Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha ± interferon gamma and melphalan in patients with irresectable soft tissue tumors

    Journal of Surgical Oncology

    Volume 65, Issue 2, June 1997, Pages: 88–94, Bart C. Vrouenraets, Ronald B. Keus, Omgo E. Nieweg and Bin B. Kroon

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1096-9098(199706)65:2<88::AID-JSO4>3.0.CO;2-J

  19. You have free access to this content
    Isolated limb perfusion with tumor necrosis factor-α and melphalan for patients with unresectable soft tissue sarcoma of the extremities

    Cancer

    Volume 98, Issue 7, 1 October 2003, Pages: 1483–1490, Eva M. Noorda, Bart C. Vrouenraets, Omgo E. Nieweg, Frits van Coevorden, Gooike W. van Slooten and Bin B. R. Kroon

    Version of Record online : 22 AUG 2003, DOI: 10.1002/cncr.11648

  20. Who Should we Consider for Isolated Limb Perfusion?

    Melanoma: Critical Debates

    Ferdy J. Lejeune, Danielle Liénard, Pages: 230–237, 2007

    Published Online : 8 OCT 2007, DOI: 10.1002/9780470987346.ch17